UB Paderborn / Katalog / Suche / in CDI

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

The Journal of heart and lung transplantation, 2019-05, Vol.38 (5), p.493-503

2019

Link zum Volltext

Verfügbarkeit prüfen

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation

The Journal of heart and lung transplantation, 2014-12, Vol.33 (12), p.1288-1294

2014

Link zum Volltext

Verfügbarkeit prüfen

Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction

The Journal of heart and lung transplantation, 2020-12, Vol.39 (12), p.1417-1425

2020

Link zum Volltext

Verfügbarkeit prüfen

Streamlining the process for initial review of pharmacy residency applications: An analytic approach

American journal of health-system pharmacy, 2013-10, Vol.70 (19), p.1670-1675

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacy Services in Heart Failure: An Opinion Paper From the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network

Journal of cardiac failure, 2013-05, Vol.19 (5), p.354-369

2013

Link zum Volltext

Verfügbarkeit prüfen

Colloids in the intensive care unit

American journal of health-system pharmacy, 2012-10, Vol.69 (19), p.1635-1642

2012

Link zum Volltext

Verfügbarkeit prüfen

A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome

Transplantation, 2017-06, Vol.101 (6), p.1215

2017

Link zum Volltext

Verfügbarkeit prüfen

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres

American journal of respiratory and critical care medicine, 2019-02, Vol.199 (3), p.362-376

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy for mechanical circulatory support: a comprehensive review

The Annals of pharmacotherapy, 2011-01, Vol.45 (1), p.60

2011

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Ventricular-Assist Device Infections Differs by Device Type

Clinical infectious diseases, 2010-09, Vol.51 (5), p.632-633

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients

American journal of transplantation, 2018-06, Vol.18 (6), p.1527-1533

2018

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation

Transplantation direct, 2018-08, Vol.4 (8), p.e372-e372

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-targeted therapy for the management of solid organ transplant recipients

Human immunology, 2019-03, Vol.80 (3), p.184-190

2019

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients

The Annals of pharmacotherapy, 2012-04, Vol.46 (4), p.558

2012

Link zum Volltext

Verfügbarkeit prüfen

Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations

The Journal of heart and lung transplantation, 2020-10, Vol.39 (10), p.1050-1069

2020

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV‐associated posttransplant lymphoproliferative disorder and worse survival

American journal of transplantation, 2020-05, Vol.20 (5), p.1439-1446

2020

Link zum Volltext

Verfügbarkeit prüfen

ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation

American journal of health-system pharmacy, 2020-01, Vol.77 (3), p.222-232

2020

Link zum Volltext

Verfügbarkeit prüfen

Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States – a retrospective study

Transplant international, 2020-08, Vol.33 (8), p.895-901

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program

American journal of health-system pharmacy, 2011-05, Vol.68 (10), p.934-939

2011

Link zum Volltext

Verfügbarkeit prüfen

A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students’ Postgraduate Readiness

American journal of pharmaceutical education, 2019-11, Vol.83 (9), p.7327-7335, Article 7327

2019

Link zum Volltext

Verfügbarkeit prüfen

Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation

Clinical transplantation, 2017-04, Vol.31 (4), p.np-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after lung transplantation for patients with occupational lung diseases

Clinical transplantation, 2019-01, Vol.33 (1), p.e13460-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier

Clinical transplantation, 2018-10, Vol.32 (10), p.e13363-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?

Human immunology, 2017-02, Vol.78 (2), p.64-71

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation

Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction

Streamlining the process for initial review of pharmacy residency applications: An analytic approach

Clinical Pharmacy Services in Heart Failure: An Opinion Paper From the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network

Colloids in the intensive care unit

A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres

Pharmacotherapy for mechanical circulatory support: a comprehensive review

The Risk of Ventricular-Assist Device Infections Differs by Device Type

Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients

Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients

A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation

Cytokine-targeted therapy for the management of solid organ transplant recipients

Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients

Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations

Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV‐associated posttransplant lymphoproliferative disorder and worse survival

ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation

Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States – a retrospective study

Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program

A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students’ Postgraduate Readiness

Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation

Outcomes after lung transplantation for patients with occupational lung diseases

Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier

Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?

Suchergebnisse filtern